BRIEF published on 11/19/2025 at 15:53, 9 months 28 days ago The Vanguard Group Discloses Stake in Qualcomm Form 8.3 The Vanguard Group Takeover Code Stock Holdings Qualcomm Incorporated
BRIEF published on 11/19/2025 at 15:52, 9 months 28 days ago The Vanguard Group Discloses Position in American Axle & Manufacturing Holdings Form 8.3 Takeover Code Stake Disclosure Vanguard American Axle
BRIEF published on 11/19/2025 at 15:50, 9 months 28 days ago The Vanguard Group Announces Shareholdings in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Vanguard Group Shareholding Avadel Pharmaceuticals
BRIEF published on 11/19/2025 at 15:49, 9 months 28 days ago The Vanguard Group Discloses Position in Mural Oncology Form 8.3 Relevant Securities Irish Takeover Panel The Vanguard Group Mural Oncology
PRESS RELEASE published on 11/19/2025 at 15:48, 9 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses a 10.67% interest in Qualcomm Incorporated. Details of securities transactions provided in Form 8.3 filing Form 8.3 Disclosure Vanguard Group Securities Transactions Qualcomm
PRESS RELEASE published on 11/19/2025 at 15:47, 9 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 7.47% stake in American Axle & Manufacturing Holdings, Inc. as of 18 November 2025 Manufacturing Vanguard Group Financial Disclosure Stake American Axle
BRIEF published on 11/19/2025 at 15:47, 9 months 28 days ago The Vanguard Group Discloses Position in Dowlais Group plc Form 8.3 Takeover Code Vanguard Group Security Disclosure Dowlais Group
PRESS RELEASE published on 11/19/2025 at 15:45, 9 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses 5.71% stake in Avadel Pharmaceuticals plc as of 18 November 2025 Irish Takeover Panel Vanguard Group Financial Disclosure Stake Disclosure Avadel Pharmaceuticals
PRESS RELEASE published on 11/19/2025 at 15:44, 9 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 1.67% stake in Mural Oncology plc as per Form 8.3 submitted on 18 November 2025 The Vanguard Group, Inc. Form 8.3 Irish Takeover Panel Stake Disclosure Mural Oncology Plc
PRESS RELEASE published on 11/19/2025 at 15:42, 9 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc The Vanguard Group, Inc. discloses a 5.49% interest in Dowlais Group plc's 1p ordinary securities as of 18 November 2025 The Vanguard Group Interest Disclosure 1p Ordinary Securities 5.49% Interest Dowlais Group Plc
Published on 09/17/2026 at 15:55, 4 hours 59 minutes ago Empress Announces Agreement to Acquire Tongon Gold Stream and Secures Debt Financing
Published on 09/17/2026 at 15:25, 5 hours 29 minutes ago AIAI Holdings' Constellation Network Launches Dôr Patient Journey with Proactive MD(R), Expanding Transformational AI In Healthcare
Published on 09/17/2026 at 15:00, 5 hours 54 minutes ago Norsemont Hits 41 Meters of 4.59 g/t Gold as Phase 3 Drilling Continues to Expand the Choquelimpie System
Published on 09/17/2026 at 15:00, 5 hours 54 minutes ago ECC Ventures 4 Announces Termination of Agreement With Cambria Gold Mines Inc.
Published on 09/17/2026 at 14:50, 6 hours 4 minutes ago Caldwell Strengthens Human Resources Practice with Addition of Ali Palmer as Partner
Published on 09/17/2026 at 19:00, 1 hour 54 minutes ago Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 18:58, 1 hour 56 minutes ago EQS-Adhoc: H2APEX Group SCA: General Partner of H2APEX Group SCA resolves to prepare for the transfer of its stock exchange listing from the Regulated Market (Prime Standard) to the Scale segment of the Frankfur
Published on 09/17/2026 at 18:25, 2 hours 29 minutes ago Magentic raises $18M to build the AI workforce for the physical world
Published on 09/17/2026 at 18:10, 2 hours 44 minutes ago A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:46, 3 hours 8 minutes ago RBI categorically denies the allegations of short-seller report
Published on 09/17/2026 at 17:40, 3 hours 14 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 3 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 13 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
